| 000 | 01426nam a2200313 a 4500 | ||
|---|---|---|---|
| 001 | vtls000047226 | ||
| 003 | KUKTEM | ||
| 005 | 20251117150400.0 | ||
| 008 | 100722t2010 flua f b 001 0 eng d | ||
| 020 | _a9781420070996 (hardcover : alk. paper) | ||
| 039 | 9 |
_a201107140043 _bVLOAD _c201104061440 _dfauzi _y201007221121 _zfarina |
|
| 040 | _aUMP | ||
| 090 | _aRM301.42 .M37 2010 | ||
| 100 | 1 | _aMartin, Yvonne Connolly | |
| 245 | 1 | 0 |
_aQuantitative drug design : _ba critical introduction / _cYvonne Connolly Martin |
| 250 | _a2nd ed. | ||
| 260 |
_aBoca Raton : _bCRC Press/Taylor & Francis, _cc2010 |
||
| 300 |
_axv, 282 p. : _bill. ; _c25 cm. |
||
| 504 | _aIncludes bibliographical references and index | ||
| 505 | 0 | _aOverview of quantitative drug design -- Noncovalent interactions in biological systems -- Preparation of 3D structures of molecules for 3D QSAR -- Calculating physical properties of molecules -- Biological data -- Form of equations that relat Methods to approach other structure-activity problems. | |
| 650 | 0 |
_aDrugs _xStructure-activity relationships |
|
| 650 | 0 | _aQSAR (Biochemistry) | |
| 650 | 0 |
_aDrugs _xDesign |
|
| 650 | 1 | 2 | _aDrug Design |
| 650 | 2 | 2 | _aBiopharmaceutics |
| 650 | 2 | 2 | _aModels, Theoretical |
| 650 | 2 | 2 | _aQuantitative Structure-Activity Relationship |
| 999 |
_aVIRTUA40 _c57219 _d57225 |
||
| 999 | _aVTLSSORT0080*0200*0400*0900*1000*2450*2500*2600*3000*5040*5050*6500*6501*6502*6503*6504*6505*6506*9991 | ||